major insurance changes are coming to glp 1 drugs The GLP-1 Access Gap: Mapping Who Can Actually Afford America's Miracle Weight-Loss Insurance coverage just changed for

Without getting too deep into the science, glucagon-like peptide-1, or GLP-1, is a hormone

A new study provides the first clinical evidence that popular semaglutide drugs, like Ozempic or Wegovy, could slow down processes associated with biological aging.

they may also have direct effects in the brain (animal studies show neuroprotection and reduced amyloid/tau pathology)

Loss of muscle mass and strength not only impairs mobility and quality of life, but also worsens insulin resistance, ...

Vegetarian capsules with chlorophyll, no artificial additives

Novo Nordisk is seeking to replace the existing glucagon-like peptide-1 (GLP-1) receptor agonist (RA) with a second-generation drug, semaglutide, to fight diabetes and obesity in Korea.On Thursday, the Ministry of Food and Drug Safety authorized the use of Novo Nordisks Ozempic to treat adults with